Concert Genetics
A leader with deep financial and operational experience, Dowdy brings a track record of success building and growing data-driven software companies to his work as CFO of Concert Genetics.
Prior to Concert, Dowdy was part of a three-person team that raised capital and bought Edgenet, a software firm offering content management and product sales configuration to suppliers, distributors, and retailers. As CFO, he positioned Edgenet for profitable growth and helped recapitalize the business. Before that, Dowdy was part of the leadership team at Asurion, the leading provider of insurance, warranty and support services for consumer electronics. There, he held finance, strategy, business development, and operational roles, ultimately serving as CFO of call center operations
Outside of work, Dowdy is a board member and chair of the finance committee for KIPP Academy Nashville, a non-profit college-preparatory institution serving elementary, middle, and high school students.
He holds an undergraduate degree in Economics and History from Duke University and a Masters in Business Administration from the University of Virginia.
This person is not in any offices
Concert Genetics
Genetic testing is the lynchpin of precision medicine, but the rapid pace of change in the market makes it enormously complex. Today, there are more than 75,000 unique genetic testing products on the market, and an average of 10 new products are added each day. This growth confounds the processes through which tests are ordered, resulted, billed and reimbursed. Founded in 2010 with a vision to simplify this complexity, Concert Genetics (formerly NextGxDx, Inc.) launched as a healthcare technology company dedicated to streamlining the genetic test selection, ordering, payment and management for clinicians, hospitals, laboratories and health plans. With a leading team of clinicians, researchers, data scientists and software engineers, Concert Genetics launched its proprietary solutions to enable end-to-end genetic testing management, from searching and comparing testing products, to tracking orders and results, to payment integrity and forecasting trends in pricing and utilization. Today, stakeholders across the healthcare system turn to Concert Genetics to better understand and navigate the rapid transformation to precision medicine that is underway.